Biopharmaceutical Industry | Impact Entrepreneur

The Case for a USA Public Benefit Biotechnology Industry

The Case for a USA Public Benefit Biotechnology Industry

by Barbara Handelin | Blended Finance & Philanthropy, Editor's Picks, Global, Impact Economy, Impact Investing, North America, SDG 3 - Good Health and Well-Being, Stakeholder Capitalism, Systems Change

Biotechnology companies in the United States have a primary duty baked into their corporate charter to maximize profits and shareholder value; as do all for-profit corporations. Unlike companies in other industries, however, biotech companies do not compete on product...